We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.62B
AUM Growth
+$771M
Cap. Flow
+$761M
Cap. Flow %
47.09%
Top 10 Hldgs %
24.76%
Holding
360
New
183
Increased
41
Reduced
36
Closed
97

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$31M
2
HOG icon
Harley-Davidson
HOG
+$29.3M
3
SJM icon
J.M. Smucker
SJM
+$27.6M
4
CSX icon
CSX Corp
CSX
+$19.9M
5
FINL
Finish Line
FINL
+$18.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$37.1M
2
AGN
Allergan Inc
AGN
+$21.6M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$13.3M
4
IMAX icon
IMAX
IMAX
+$11.9M
5
AMCX icon
AMC Global Media
AMCX
+$9.63M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.72%
2 Technology 9.42%
3 Industrials 6.31%
4 Healthcare 4.42%
5 Consumer Staples 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KELYA icon
226
Kelly Services Class A
KELYA
$521M
$1.06M 0.07%
60,682
-90,058
-60% -$1.54M
VIRX
227
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$980K 0.06%
+1,905
New +$961K
INFA
228
DELISTED
INFORMATICA CORP
INFA
$967K 0.06%
+22,044
New +$917K
VYX icon
229
CALL
NCR Voyix
VYX
$1.12B
$962K 0.06%
+53,138
New +$924K
RNWK
230
DELISTED
RealNetworks Inc
RNWK
$875K 0.05%
+130,000
New +$895K
HAL icon
231
CALL
Halliburton
HAL
$26.4B
$864K 0.05%
19,700
-2,200
-10% -$91.7K
CAB
232
DELISTED
Cabela's Inc
CAB
$840K 0.05%
+15,000
New +$829K
TVTX icon
233
CALL
Travere Therapeutics
TVTX
$5.33B
$839K 0.05%
+35,000
New +$534K
DYAX
234
DELISTED
DYAX CORPORATION
DYAX
$838K 0.05%
+50,000
New +$778K
INSY
235
DELISTED
Insys Therapeutics, Inc.
INSY
$814K 0.05%
28,000
-137,000
-83% -$3.62M
CMCSA icon
236
CALL
Comcast
CMCSA
$84B
$768K 0.05%
+27,200
New +$782K
ETRM
237
DELISTED
EnteroMedics Inc.
ETRM
$755K 0.05%
786
+524
+200% +$632K
SYY icon
238
CALL
Sysco
SYY
$40.6B
$641K 0.04%
17,000
+2,400
+16% +$94.6K
PTCT icon
239
PTC Therapeutics
PTCT
$6.26B
$637K 0.04%
+10,466
New +$639K
ARMK icon
240
Aramark
ARMK
$15.1B
$633K 0.04%
+27,700
New +$634K
AMAG
241
DELISTED
AMAG Pharmaceuticals
AMAG
$629K 0.04%
+11,500
New +$548K
GSAT icon
242
Globalstar
GSAT
$10.3B
$621K 0.04%
12,440
-12,142
-49% -$501K
LPCN icon
243
Lipocine
LPCN
$17.4M
$621K 0.04%
+5,294
New +$576K
TVTX icon
244
Travere Therapeutics
TVTX
$5.33B
$599K 0.04%
+25,000
New +$381K
INFI
245
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$587K 0.04%
+42,000
New +$642K
APOL
246
CALL
DELISTED
Apollo Education Group Inc Class A
APOL
$568K 0.04%
+30,000
New +$792K
INSM icon
247
PUT
Insmed
INSM
$22B
$562K 0.03%
+27,000
New +$476K
ZAYO
248
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$559K 0.03%
+20,000
New +$570K
LVS icon
249
CALL
Las Vegas Sands
LVS
$32.3B
$550K 0.03%
+10,000
New +$557K
VXX
250
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$525K 0.03%
+1,281
New +$622K
8 9
10
11 12

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q1 2015 Portfolio in Review

As of Q1 2015, J. Goldman & Co held 360 positions worth $1.62B, up 91% from $844M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

J. Goldman & Co deployed $761M of net new capital in Q1 2015, opening 183 new positions and adding to 41 existing holdings. Its largest new stake was J.M. Smucker: 251,375 shares worth $29.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 5.4% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $37.1M trimmed.

  • J. Goldman & Co's largest Q1 2015 buy was J.M. Smucker: 251,375 shares worth $29.1M.
  • J. Goldman & Co added most to Apple in Q1 2015, an estimated $31M increase.
  • J. Goldman & Co's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $37.1M.
  • J. Goldman & Co fully exited Allergan Inc in Q1 2015, selling an estimated $21.6M.
  • J. Goldman & Co's ten largest holdings make up 25% of its $1.62B portfolio in Q1 2015.
  • J. Goldman & Co opened 183 new positions and closed 97 in Q1 2015.
  • J. Goldman & Co's portfolio value rose 91% quarter-over-quarter to $1.62B.

Based on J. Goldman & Co's 13F filing for Q1 2015, filed 18 May 2015.